Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia.
Nowrousian
M R
MR
D000740:Anemia / Q000209:etiology* / Q000517:prevention & control* / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin